These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21690286)

  • 1. Synergistic effect of antituberculosis drugs and azoles in vitro against Histoplasma capsulatum var. capsulatum.
    Cordeiro Rde A; Marques FJ; Brilhante RS; Rocha de Castro E Silva K; Mourão CI; Caetano EP; Fechine MA; Ribeiro JF; Castelo-Branco Dde S; de Lima RA; Mesquita JR; Monteiro AJ; Rocha FA; Rocha MF; Sidrim JJ
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4482-4. PubMed ID: 21690286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
    Cordeiro Rde A; Brilhante RS; Rocha MF; Medrano DJ; Monteiro AJ; Tavares JL; de Lima RA; de Camargo ZP; Sidrim JJ
    Int J Antimicrob Agents; 2009 Sep; 34(3):278-80. PubMed ID: 19520551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.
    Li RK; Ciblak MA; Nordoff N; Pasarell L; Warnock DW; McGinnis MR
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1734-6. PubMed ID: 10817743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of isavuconazole against fluconazole-resistant isolates of Histoplasma capsulatum.
    Spec A; Connolly P; Montejano R; Wheat LJ
    Med Mycol; 2018 Oct; 56(7):834-837. PubMed ID: 29253204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil.
    Brilhante RSN; Guedes GMM; Silva MLQD; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
    Int J Antimicrob Agents; 2018 Aug; 52(2):272-277. PubMed ID: 29592837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciprofloxacin shows synergism with classical antifungals against Histoplasma capsulatum var. capsulatum and Coccidioides posadasii.
    Brilhante RS; Caetano EP; Sidrim JJ; Cordeiro RA; Camargo ZP; Fechine MA; Lima RA; Castelo Branco DS; Marques FJ; Mesquita JR; Lima DT; Monteiro AJ; Rocha MF
    Mycoses; 2013 May; 56(3):397-401. PubMed ID: 23205615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro sensitivity of Histoplasma capsulatum var. capsulatum to amphotericin B, ketoconazole, itroconazole and fluconazole].
    Andreu CM; León AM; Medina YE; Machín GM; Lancha MR; Zaragozí MT
    Rev Cubana Med Trop; 2003; 55(2):76-82. PubMed ID: 15849960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antifungal activity in vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum.
    de Aguiar Cordeiro R; de Farias Marques FJ; de Aguiar Cordeiro R; da Silva MR; Donato Maia Malaquias A; Silva de Melo CV; Mafezoli J; Ferreira de Oliveira Mda C; Nogueira Brilhante RS; Gadelha Rocha MF; Pinheiro Gomes Bandeira Tde J; Costa Sidrim JJ
    Antimicrob Agents Chemother; 2014 May; 58(5):2504-11. PubMed ID: 24514090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histoplasma capsulatum in planktonic and biofilm forms: in vitro susceptibility to amphotericin B, itraconazole and farnesol.
    Brilhante RSN; de Lima RAC; Marques FJF; Silva NF; Caetano ÉP; Castelo-Branco DSCM; Bandeira TJPG; Moreira JLB; Cordeiro RA; Monteiro AJ; Camargo ZP; Sidrim JJC; Rocha MFG
    J Med Microbiol; 2015 Apr; 64(Pt 4):394-399. PubMed ID: 25657300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
    Swinne D; Watelle M; Nolard N
    Rev Iberoam Micol; 2005 Mar; 22(1):24-8. PubMed ID: 15813679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral drugs saquinavir and ritonavir reduce inhibitory concentration values of itraconazole against Histoplasma capsulatum strains in vitro.
    Brilhante RS; Caetano ÉP; Riello GB; Guedes GM; Castelo-Branco Dde S; Fechine MA; Oliveira JS; Camargo ZP; Mesquita JR; Monteiro AJ; Cordeiro Rde A; Rocha MF; Sidrim JJ
    Braz J Infect Dis; 2016; 20(2):155-9. PubMed ID: 26748233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole.
    Wheat LJ; Connolly P; Smedema M; Durkin M; Brizendine E; Mann P; Patel R; McNicholas PM; Goldman M
    J Antimicrob Chemother; 2006 Jun; 57(6):1235-9. PubMed ID: 16627592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activities of three triazoles with caspofungin against Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods.
    Kiraz N; Dag I; Yamac M; Kiremitci A; Kasifoglu N; Oz Y
    Antimicrob Agents Chemother; 2010 May; 54(5):2244-7. PubMed ID: 20194697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain.
    Cuenca-Estrella M; Díaz-Guerra TM; Mellado E; Monzón A; Rodríguez-Tudela JL
    Eur J Clin Microbiol Infect Dis; 1999 Jun; 18(6):432-5. PubMed ID: 10442422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.
    Nguyen MH; Yu CY
    J Antimicrob Chemother; 1998 Aug; 42(2):253-6. PubMed ID: 9738846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa.
    Pfaller MA; Zhang J; Messer SA; Brandt ME; Hajjeh RA; Jessup CJ; Tumberland M; Mbidde EK; Ghannoum MA
    Antimicrob Agents Chemother; 1999 Jan; 43(1):169-71. PubMed ID: 9869586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens.
    Espinel-Ingroff A
    J Clin Microbiol; 1998 Jan; 36(1):198-202. PubMed ID: 9431946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein Binding of First-Line Antituberculosis Drugs.
    Alghamdi WA; Al-Shaer MH; Peloquin CA
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis].
    Carrillo-Muñoz AJ; Cárdenes CD; Carrillo-Orive B; Rodríguez V; Del Valle O; Casals JB; Ezkurra PA; Quindós G
    Rev Iberoam Micol; 2005 Jun; 22(2):110-3. PubMed ID: 16107170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.